Health care startups in Europe
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Fresha | London | Series C | $80.0M | 2026-05-21 |
| bit.bio | Cambridge | Series D | $25.0M | 2026-11-04 |
| T-Therapeutics | Cambridge | Series B | $133.0M | 2026-11-05 |
| Basecamp Research | London | Series C | $140.0M | 2026-09-23 |
| Biolevate | Paris | Series A | $34.4M | 2026-09-21 |
| Biorce | Barcelona | Series A | $52.0M | 2026-02-02 |
| Nabla | Paris | Series C | $70.0M | 2025-06-17 |
| Brainomix | Oxford | Series C | $6.5M | 2026-02-24 |
8 rows of the CSV in 5 of its 18 columns.
- The 4,906 health care startups in Europe have raised $42.2B in total.
- 503 of them closed their most recent round in the last 12 months, $7.9B combined.
- The largest of those rounds is Neko Health's $700.0M Series C, dated July 2026.
- The most recent is SRTD Biotech's $35.2M seed round on 9 November 2026.
- HTGF (High-Tech Gruenderfonds) is an investor in 74 of them, more than any other fund.
- Biotech is the most common other sector, with 1,562 companies (32%).
- 38% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 1 to 10 employees (51% of companies with a recorded size).
- 3 are unicorns, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 4,906| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| T-Therapeutics | T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. | Biotech | Cambridge, United Kingdom | Series B | $133.0M | 2026-11-05 | $224.6M | F-Prime, Sofinnova Partners, Digitalis Ventures +2 | 51 to 100 | 2022 |
| Laza Medical | Laza Medical produces AI-powered robotic imaging systems for cardiovascular treatments. | Artificial intelligence | Pfaffikon, Switzerland | Series B | $160.0M | 2026-11-04 | $196.0M | Page One Ventures, Unorthodox Ventures, The Capital Partnership | 1 to 10 | 2020 |
| bit.bio | Bit.bio provides engineered human cell products and platform services for biomedical research and drug discovery. | Biotech | Cambridge, United Kingdom | Series D | $25.0M | 2026-11-04 | $250.0M | Metaplanet, Foresite Capital | 101 to 250 | 2016 |
| OSSTEC | OSSTEC develops products for orthopaedic treatment. | Hardware | London, United Kingdom | Series A | $8.0M | 2026-11-03 | $12.7M | SFC Capital, Parkwalk Advisors, Embryo Ventures +1 | 11 to 50 | 2021 |
| Bioliberty | Bioliberty develops rehabilitation solutions for degenerative and traumatic conditions as a medtech start-up. | Biotech | Edinburgh, United Kingdom | Series A | $3.3M | 2026-11-02 | $17.4M | Innovate UK, Scottish Enterprise, Old College Capital +2 | 11 to 50 | 2020 |
| Adsilico | Adsilico develops new approaches to medical device innovation. | Health care | Leeds, United Kingdom | Series A | $13.3M | 2026-10-26 | $17.8M | Parkwalk Advisors, Northern Gritstone | 1 to 10 | 2022 |
| Avea Life | Avea Life formulates science-based longevity supplements in Switzerland. | Health care | Zug, Switzerland | Angel | $2.2M | 2026-10-20 | $7.6M | Maximon | 1 to 10 | 2021 |
| Cellbox Solutions | Cellbox Solutions provides logistics solutions for the global biomedical industry. | Biotech | Cologne, Germany | Series A | $1.7M | 2026-10-20 | $15.3M | European Innovation Council, Fraunhofer Venture, CK Venture Capital | 11 to 50 | 2017 |
| Microbiotica | Microbiotica develops live bacterial microbiome therapeutics and associated biomarkers. | Biotech | Cambridge, United Kingdom | Series C | $47.9M | 2026-10-16 | $130.7M | Seventure Partners, IP Group, Cambridge Innovation Capital +1 | 11 to 50 | 2016 |
| Sava Technology | Sava Technology creates under-skin sensors that continuously monitor glucose, lactate, and ketones. | Biotech | London, United Kingdom | Series B | $36.0M | 2026-10-09 | $62.8M | SOSV, Balderton Capital, Social Starts +1 | 101 to 250 | 2016 |
| Archeon | Archeon develops solutions for monitoring, diagnosing, and treating critically ill patients. | Health care | Besançon, France | Series A | $9.0M | 2026-10-06 | $15.1M | Bpifrance, Daphni, Karot Capital +1 | 11 to 50 | 2018 |
| Gekko Photonics | Gekko Photonics is a European developer of photonics technology. | Energy | Wroclaw, Poland | Seed | $1.0M | 2026-09-30 | $3.0M | FundingBox Deep Tech Fund, Akcelerator Technologiczny Gliwice Sp. z o.o., Scanderia Venture | 11 to 50 | 2019 |
| Aptadir Therapeutics | Aptadir Therapeutics develops RNA-based therapies for Myelodysplastic Neoplasms. | Biotech | Milan, Italy | Seed | $45.5M | 2026-09-29 | $47.1M | CDP Venture Capital, Angelini Ventures | 1 to 10 | 2024 |
| Dyad | Dyad builds trust in data and develops AI-powered tools for healthcare operations. | Artificial intelligence | London, United Kingdom | Series A | $10.0M | 2026-09-29 | $14.0M | Plug and Play, Pantera Capital, Carbide Ventures | 11 to 50 | 2020 |
| Directed Systems | Directed Systems builds medical software and applies data science to healthcare. | Hardware | Cambridge, United Kingdom | Seed | $25K | 2026-09-27 | $25K | Innovate UK | 11 to 50 | 2014 |
| Living Optics | Living Optics develops imaging technology. | Artificial intelligence | Milton Keynes, United Kingdom | Series A | $20.0M | 2026-09-24 | $49.3M | Octopus Ventures, Oxford Science Enterprises, Outsized Ventures +2 | 11 to 50 | 2020 |
| Basecamp Research | Basecamp Research is a biotechnology company that uses AI and biological data to develop therapeutics. | Artificial intelligence | London, United Kingdom | Series C | $140.0M | 2026-09-23 | $219.9M | True Ventures, redalpine, Hummingbird Ventures +1 | 51 to 100 | 2019 |
| Dialybrid | Dialybrid develops vascular grafts for hemodialysis made from silk fibroin and polyurethane. | Health care | Cantù, Italy | Series A | $17.2M | 2026-09-22 | $17.6M | LIFTT | 1 to 10 | 2020 |
| Incepto Medical | Incepto Medical develops artificial intelligence software for medical imaging. | Artificial intelligence | Paris, France | Series B | $16.0M | 2026-09-22 | $49.2M | Bpifrance, AVP, Karista +2 | 51 to 100 | 2018 |
| Biolevate | Biolevate provides an AI platform that helps life sciences teams run regulated operations with auditable workflows. | Artificial intelligence | Paris, France | Series A | $34.4M | 2026-09-21 | $40.7M | Bpifrance, EQT Ventures | 11 to 50 | 2024 |
| Matisse Pharmaceuticals | Matisse Pharmaceuticals develops therapies for sepsis and septic shock by targeting cytotoxic histones. | Biotech | Geleen, The Netherlands | Series A | $16.0M | 2026-09-17 | $22.0M | Brightlands Venture Partners, Chemelot Ventures, Limburg Business Development Fund (LBDF) | 11 to 50 | 2014 |
| Tandem Health | Tandem Health develops AI tools for clinical documentation, coding, decision support, and follow-up in healthcare. | Artificial intelligence | Stockholm, Sweden | Series B | $100.0M | 2026-09-14 | $159.7M | Northzone, Amino Collective | 101 to 250 | 2023 |
| Allogenetics | Allogenetics addresses organ rejection following transplantation. | Health care | Hanover, Germany | Seed | $4.4M | 2026-09-09 | $8.2M | NBank Capital, Carma Fund | 1 to 10 | 2022 |
| Hope Care Health | Hope Care created OpMA, a regulated software device that unifies outpatient remote monitoring to support Hospital-at-Home. | Health care | Óbidos, Portugal | Series A | $7.0M | 2026-09-08 | $7.0M | GED Ventures Portugal | 11 to 50 | 2012 |
| Healthplus.ai | Healthplus.ai uses AI to predict post-operative infection risks for surgical patients. | Artificial intelligence | Amsterdam, The Netherlands | Seed | $3.8M | 2026-09-03 | $8.9M | Cedars-Sinai Accelerator, European Commission, LUMO labs | 11 to 50 | 2017 |
| Amyl Therapeutics | Amyl Therapeutics is a preclinical biotechnology company developing immunotherapy for neurodegenerative diseases. | Biotech | Liège, Belgium | Series A | $9.6M | 2026-09-01 | $44.0M | Meusinvest (Noshaq), Sambrinvest, Mérieux Equity Partners +1 | 1 to 10 | 2020 |
| NovaGo Therapeutics | NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. | Biotech | Schlieren, Switzerland | Series B | $29.7M | 2026-08-31 | $39.7M | Kinled Holding, Pureos Bioventures | 1 to 10 | 2015 |
| Kynexis | Kynexis develops precision medicine treatments for cognitive impairment associated with schizophrenia. | Biotech | Naarden, The Netherlands | Series A | $112.3M | 2026-08-19 | $173.3M | Forbion Capital Partners, Ysios Capital, Sunstone Life Science Ventures | 11 to 50 | 2023 |
| Bewelab SA | Bewelab SA uses neuroscience-based digital interventions to reduce cravings at the neural level. | Health care | Fribourg, Switzerland | Seed | $2.5M | 2026-08-19 | $5.5M | Future of Health Grant, Fribourg Innovation | 1 to 10 | 2021 |
| Unikum.net | Unikum.net operates a European PreK-12 cloud platform for schools and students. | Artificial intelligence | Stockholm, Sweden | Series A | $700K | 2026-08-18 | $2.7M | JCE Group, Tequity | 51 to 100 | 2005 |
Table 1. Health care startups in Europe: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 4,906.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CellCentric | CellCentric develops small molecule therapies for treating cancer and multiple myeloma. | Biotech | Cambridge, United Kingdom | Series D | $220.0M | 2026-05-06 | $475.7M | Innovate UK, 5Y Capital, RA Capital Management +2 | 11 to 50 | 2003 |
| 2 | Windward Bio | Windward Bio develops monoclonal antibodies for advanced immunological diseases. | Biotech | Basel, Switzerland | Series B | $165.0M | 2026-05-04 | $365.0M | Qiming Venture Partners, OrbiMed, Novo Holdings +2 | 11 to 50 | 2024 |
| 3 | Laza Medical | Laza Medical produces AI-powered robotic imaging systems for cardiovascular treatments. | Artificial intelligence | Pfaffikon, Switzerland | Series B | $160.0M | 2026-11-04 | $196.0M | Page One Ventures, Unorthodox Ventures, The Capital Partnership | 1 to 10 | 2020 |
| 4 | Vaderis Therapeutics | Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. | Biotech | Basel, Switzerland | Series B | $152.0M | 2026-08-11 | $170.6M | Medicxi | 11 to 50 | 2019 |
| 5 | Basecamp Research | Basecamp Research is a biotechnology company that uses AI and biological data to develop therapeutics. | Artificial intelligence | London, United Kingdom | Series C | $140.0M | 2026-09-23 | $219.9M | True Ventures, redalpine, Hummingbird Ventures +1 | 51 to 100 | 2019 |
| 6 | T-Therapeutics | T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. | Biotech | Cambridge, United Kingdom | Series B | $133.0M | 2026-11-05 | $224.6M | F-Prime, Sofinnova Partners, Digitalis Ventures +2 | 51 to 100 | 2022 |
| 7 | Kynexis | Kynexis develops precision medicine treatments for cognitive impairment associated with schizophrenia. | Biotech | Naarden, The Netherlands | Series A | $112.3M | 2026-08-19 | $173.3M | Forbion Capital Partners, Ysios Capital, Sunstone Life Science Ventures | 11 to 50 | 2023 |
| 8 | Tandem Health | Tandem Health develops AI tools for clinical documentation, coding, decision support, and follow-up in healthcare. | Artificial intelligence | Stockholm, Sweden | Series B | $100.0M | 2026-09-14 | $159.7M | Northzone, Amino Collective | 101 to 250 | 2023 |
| 9 | Fresha | Fresha is a marketplace platform that helps users find nearby beauty, wellness, and self-care services. | Commerce | London, United Kingdom | Series C | $80.0M | 2026-05-21 | $299.0M | FJ Labs, Partech, Target Global +2 | 251 to 500 | 2015 |
| 10 | ADCendo | ADCendo develops antibody-drug conjugates to target cancers with high unmet medical needs. | Biotech | Copenhagen, Denmark | Series C | $75.0M | 2026-04-14 | $324.6M | RA Capital Management, Novo Holdings, Gilde Healthcare +2 | 51 to 100 | 2017 |
Table 2. Health care startups in Europe: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | 74 | 2% | 5 | CereGate, Tacalyx, mbiomics |
| 2 | Venture Kick | Startup incubator | Schlieren, Switzerland | 51 | 1% | 1 | Genknowme |
| 3 | Bpifrance | Government investment office | Maisons-alfort, France | 50 | 1% | 4 | Archeon, Incepto Medical, Biolevate |
| 4 | Innovate UK | Entrepreneurship program | Swindon, United Kingdom | 46 | 1% | 10 | Bioliberty, Directed Systems, Neuronostics |
| 5 | Techstars | Startup accelerator | New York, United States | 32 | 1% | 2 | Xena, dehaze |
| 6 | European Innovation Council | Startup accelerator | Brussels, Belgium | 28 | 1% | 2 | Cellbox Solutions, Vitestro |
| 7 | Antler | Venture capital firm | Singapore | 24 | 0% | 1 | Alcolase |
| 8 | Plug and Play | Startup accelerator | Sunnyvale, United States | 20 | 0% | 3 | Dyad, Apoha, Biorce |
| 9 | Bayern Kapital | Venture capital firm | Landshut, Germany | 20 | 0% | 1 | mbiomics |
| 10 | KfW | Government investment office | Frankfurt, Germany | 20 | 0% | ||
| 11 | Octopus Ventures | Venture capital firm | London, United Kingdom | 17 | 0% | 3 | Living Optics, Semble, KatKin |
| 12 | Innosuisse | Government investment office | Berne, Switzerland | 17 | 0% | 1 | ORamaVR |
| 13 | Verve Ventures | Venture capital firm | Zug, Switzerland | 16 | 0% | 1 | Nuclera |
| 14 | MassChallenge | Startup accelerator | Boston, United States | 16 | 0% | 2 | Octarine Bio, The Blue Box Biomedical Solutions |
| 15 | Bethnal Green Ventures | Startup accelerator | London, United Kingdom | 16 | 0% |
Table 3. Health care startups in Europe: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 1,562 | 32% | $24.5B |
| Software | 1,451 | 30% | $9.6B |
| Artificial intelligence | 571 | 12% | $6.4B |
| Hardware | 316 | 6% | $934.7M |
| Commerce | 213 | 4% | $641.9M |
| Education | 139 | 3% | $515.2M |
| Fintech | 127 | 3% | $1.8B |
| Cybersecurity | 20 | 0% | $94.2M |
| Energy | 12 | 0% | $47.8M |
Table 4. Health care startups in Europe by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Health care startups in Europe by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Companies | Share |
|---|---|---|
| United Kingdom | 1,388 | 28% |
| Germany | 659 | 13% |
| France | 526 | 11% |
| Switzerland | 353 | 7% |
| The Netherlands | 282 | 6% |
| Spain | 261 | 5% |
| Italy | 190 | 4% |
| Sweden | 174 | 4% |
| Poland | 142 | 3% |
| Ireland | 135 | 3% |
| Denmark | 131 | 3% |
| Belgium | 121 | 2% |
Table 6. Health care startups in Europe by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Health care startups in Europe by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 14 | 3% | $507.8M |
| October 2026 | 45 | 9% | $775.5M |
| September 2026 | 76 | 15% | $923.7M |
| August 2026 | 16 | 3% | $404.2M |
| July 2026 | 40 | 8% | $1.1B |
| June 2026 | 62 | 12% | $1.3B |
| May 2026 | 34 | 7% | $740.7M |
| April 2026 | 33 | 7% | $393.7M |
| March 2026 | 36 | 7% | $236.4M |
| February 2026 | 45 | 9% | $285.4M |
| January 2026 | 44 | 9% | $568.1M |
| December 2025 | 37 | 7% | $431.5M |
| November 2025 | 21 | 4% | $232.2M |
Table 8. Health care startups in Europe: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 445 | 9% | $7.2B |
| 2025 | 574 | 12% | $5.6B |
| 2024 | 544 | 11% | $5.0B |
| 2023 | 590 | 12% | $3.0B |
| 2022 | 629 | 13% | $3.4B |
| 2021 | 436 | 9% | $3.7B |
Table 9. Health care startups in Europe by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 584 | 12% |
| 2020 to 2022 | 1,254 | 26% |
| 2015 to 2019 | 1,794 | 37% |
| 2010 to 2014 | 759 | 16% |
| Before 2010 | 454 | 9% |
Table 10. Health care startups in Europe by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 2,460 | 51% |
| 11 to 50 | 1,853 | 39% |
| 51 to 100 | 264 | 6% |
| 101 to 250 | 137 | 3% |
| 251 to 500 | 35 | 1% |
| 501 to 1,000 | 24 | 1% |
| 1,001 to 5,000 | 14 | 0% |
| 5,001 to 10,000 | 2 | 0% |
| 10,001 or more | 7 | 0% |
Table 11. Health care startups in Europe by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its headquarters is in Europe. On 16 November 2026 that is 4,906 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 4,906 rows: 1,260 have no round amount, 0 no city and 1,810 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Europe are on the list?
- 4,906, in the file dated 16 November 2026. 503 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 4,906 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.